Literature DB >> 1871716

Cellular localization of activated factor X by Xa-specific probes.

L R Zacharski1, C Dunwiddie, E M Nutt, J Hunt, V A Memoli.   

Abstract

A probe, recombinant antistasin, that reacts specifically with the activated form of factor X (Xa) was used in immunohistochemical procedures to detect cellular sites of Xa generation within intact tissues. Factor Xa was detected on tumor cells in small cell carcinoma of the lung, renal cell carcinoma, and malignant melanoma. Tumor-associated macrophages (but not tumor cells) expressed Xa in adenocarcinoma and squamous cell carcinoma of the lung, and Hodgkin's disease. Factor Xa in these locations corresponded to evidence reported previously for an intact coagulation pathway and thrombin formation associated with these tumor cells and macrophages. By contrast, only rare connective tissue cells stained for Xa in breast and colon cancer, tumor types shown previously to lack an intratumoral coagulation pathway and thrombin generation, and in normal liver, lung, breast, kidney, and placental tissues. Hepatocytes did not stain. These results suggest that such probes may be useful for studying the activation state of cell-associated factor X in situ within intact tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871716

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  Anticoagulation, ferrotoxicity and the future of translational lung cancer research.

Authors:  Leo R Zacharski
Journal:  Transl Lung Cancer Res       Date:  2016-06

2.  Immunohistochemical studies of human tissues with antibody to factor Xa.

Authors:  T Yamada; Y Nagai
Journal:  Histochem J       Date:  1996-01

3.  MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.

Authors:  Hanaa Aissaoui; Célia Prévost; Ahmed Boucharaba; Kamel Sanhadji; Jean-Claude Bordet; Claude Négrier; Habib Boukerche
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

4.  In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes.

Authors:  J Contrino; G A Hair; M A Schmeizl; F R Rickles; D L Kreutzer
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

Review 5.  Clinical trials with anticoagulant and antiplatelet therapies.

Authors:  L R Zacharski; K R Meehan; S M Algarra; F A Calvo
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 6.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 7.  Activation of blood coagulation in cancer: implications for tumour progression.

Authors:  Luize G Lima; Robson Q Monteiro
Journal:  Biosci Rep       Date:  2013-09-04       Impact factor: 3.840

Review 8.  Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.